Placenta accreta spectrum (PAS) disorders are characterized by abnormal trophoblastic invasion into the myometrium, leading to significant maternal health risks. PAS includes placenta accreta (invasion < 50% of the myometrium), increta (invasion > 50%), and percreta (invasion through the entire myometrium). The condition is most associated with previous cesarean deliveries and increases in chance with the number of prior cesarians. The increasing global cesarean rates heighten the importance of early PAS diagnosis and management. This review explores genetic expression and key regulatory processes, such as apoptosis, cell proliferation, invasion, and inflammation, focusing on signaling pathways, genetic expression, biomarkers, and non-coding RNAs involved in trophoblastic invasion. It compiles the recent scientific literature (2014–2024) from the Scopus, PubMed, Google Scholar, and Web of Science databases. Identifying new biomarkers like AFP, sFlt-1, β-hCG, PlGF, and PAPP-A aids in early detection and management. Understanding genetic expression and non-coding RNAs is crucial for unraveling PAS complexities. In addition, aberrant signaling pathways like Notch, PI3K/Akt, STAT3, and TGF-β offer potential therapeutic targets to modulate trophoblastic invasion. This review underscores the need for interdisciplinary care, early diagnosis, and ongoing research into PAS biomarkers and molecular mechanisms to improve prognosis and quality of life for affected women.

The global burden of cancer is on the rise, with varying national patterns. To gain a better understanding and control of cancer, it is essential to provide national estimates. Therefore, we present a comparative description of cancer incidence and mortality rates in Mexico from 1990 to 2019, by age and sex for 29 different cancer groups. Based on public data from the Global Burden of Disease Study 2019, we evaluated the national burden of cancer by analyzing counts and crude and age-standardized rates per 100,000 people with 95% uncertainty intervals for 2019 and trends using the annual percentage change from 1990 to 2019. In 2019, cancer resulted in 222,060 incident cases and 105,591 deaths. In 2019, the highest incidence of cancer was observed in non-melanoma skin cancer, prostate cancer, and breast cancer. Additionally, 53% of deaths were attributed to six cancer groups (lung, colorectal, stomach, prostate, breast, and pancreatic). From 1990 to 2019, there was an increasing trend in incidence and mortality rates, which varied by 10–436% among cancer groups. Furthermore, there were cancer-specific sex differences in crude and age-standardized rates. The results show an increase in the national cancer burden with sex-specific patterns of change. These findings can guide national efforts to reduce health loss due to cancer.

Placenta accreta spectrum (PAS) disorders are characterized by abnormal trophoblastic invasion into the myometrium, leading to significant maternal health risks. PAS includes placenta accreta (invasion 50%), and percreta (invasion through the entire myometrium). The condition is most associated with previous cesarean deliveries, and its incidence increases with the number of cesareans. Other risk factors include advanced maternal age, multiparity, and various uterine surgeries. The increasing global cesarean rates heighten the importance of early PAS diagnosis and management. The study reviewed molecular mechanisms driving PAS, focusing on signaling pathways, genetic expression, biomarkers, and non-coding RNAs involved in trophoblastic invasion. It explored genetic expression and key regulatory processes such as apoptosis, cell proliferation, invasion, and inflammation. The manuscript was compiled from recent scientific literature (2014 – 2024) from the Scopus, PubMed, Google Scholar, and Web of Science databases. Placenta Acreta Spectrum; acreta; increta; percreta; trophoblast invasion; miRNAs, lncRNAs; genetic expression; biomarkers; signaling pathways were the employed keywords to compile relevant literature. The PAS is an important obstetric health problem that challenges maternal health risks associated with abnormal trophoblastic invasion that relies on abnormal placentation, uterine scarring, and impaired decidualization. Identifying new biomarkers like AFP, sFlt-1, β-hCG, PlGF, and PAPP-A aids early detection and management. Understanding genetic expression and non-coding RNAs is crucial for unraveling PAS complexities. Besides, aberrant signaling pathways like Notch, PI3K/Akt, STAT3, and TGF-β offer potential therapeutic targets to modulate trophoblastic invasion. This review underscores the need for interdisciplinary care, early diagnosis, and ongoing research into PAS biomarkers and molecular mechanisms to improve prognosis and quality of life for affected women.

The cancer burden is increasing worldwide with contrasting national patterns. Therefore, providing national estimations is necessary to understand and control this health issue. Herein, we comparatively describe incidence, mortality, and disability-adjusted lived years (DALYs) due to 29 groups of cancer in Mexico from 1990 to 2019 by sex and age. Using public data from the Global Burden of Disease Study 2019, we assessed the national burden of cancer using counts and crude and age-standardized rates per 100,000 people with 95% uncertainty intervals for 2019 and their trends using the annual percentage of change from 1990 to 2019. In 2019, cancer caused 222,060 incident cases, 105,591 deaths, and 2,86,054 DALYs in the general population. Nonmelanoma skin cancer, prostate cancer, and breast cancer had the highest incidence, and six groups of cancer (lung, colorectal, stomach, prostate, breast, and pancreatic) caused 53% of the deaths in 2019. From 1990 to 2019, incidence and mortality showed an increasing trend that varied between 10% and 436% among the groups of cancer, whereas the crude and age-standardized rates showed cancer-specific sex disparities. Our results demonstrate a substantial growth of the national burden of cancer with sex-specific patterns of change. These results may guide national efforts toward reducing health loss due to cancer.

The use of botanical extracts derived from Jatropha spp. offers a sustainable alternative for controlling insect pests, thereby reducing the reliance on synthetic chemical insecticides. A systematic review and meta-analysis was conducted to summarize the published evidence on the insecticidal activity of these extracts. Electronic database searches were conducted to identify relevant studies evaluating Jatropha ssp. botanical extracts against insect pests, including mortality, antifeedant activity, time of development, oviposition inhibition, and repellency. A random-effects meta-analysis for continuous variables with 95% confidence intervals was employed to compare treated insects against a control group. The study encompassed 77 articles, which evaluated the extracts from various botanical parts of J. curcas and J. gossypifolia against insects from nine taxonomic orders. The results of the meta-analyses demonstrated that aqueous, ethanolic, and methanolic extracts from leaves and seeds were effective in increasing the mortality rate of treated insects. These extracts also affected the insects by prolonging development time, reducing weight gain in larvae and pupae, inhibiting oviposition, and increasing the percentage of repellency. Consequently, botanical extracts obtained from the leaves and seeds of J. curcas and J. gossypifolia should be considered a sustainable and agroecological alternative for pest management.

The use of botanical extracts derived from Jatropha spp. offers a sustainable alternative for controlling insect pests, thereby reducing reliance on synthetic chemical insecticides. A systematic review and meta-analysis were conducted to summarize the published evidence on the insecticidal activity of these extracts. Electronic database searches were conducted to identify relevant studies evaluating Jatropha spp. botanical extracts against insect pests, including mortality, antifeedant activity, time of development, oviposition inhibition, and repellency. A random-effects meta-analysis for continuous variables with 95% confidence intervals was employed to compare treated insects against a control group. The study encompassed 77 articles, which evaluated extracts from various botanical parts of Jatropha curcas and Jatropha gossypifolia against insects from nine taxonomic orders. The results of the meta-analyses demonstrated that aqueous, ethanolic, and methanolic extracts from leaves and seeds were effective in increasing the mortality rate of treated insects. These extracts also affected the insects by prolonging development time, reducing weight gain in larvae and pupae, inhibiting oviposition, and increasing the percentage of repellency. Consequently, the foliar application of botanical extracts obtained from the leaves and seeds of J. curcas and J. gossypifolia represent a sustainable and agroecological alternative for the control of insect pests from different taxonomic orders.